Andrew L. Clark

22.8k total citations · 2 hit papers
389 papers, 13.4k citations indexed

About

Andrew L. Clark is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Complementary and alternative medicine. According to data from OpenAlex, Andrew L. Clark has authored 389 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 296 papers in Cardiology and Cardiovascular Medicine, 63 papers in Pulmonary and Respiratory Medicine and 47 papers in Complementary and alternative medicine. Recurrent topics in Andrew L. Clark's work include Heart Failure Treatment and Management (204 papers), Cardiovascular Function and Risk Factors (132 papers) and Cardiac pacing and defibrillation studies (78 papers). Andrew L. Clark is often cited by papers focused on Heart Failure Treatment and Management (204 papers), Cardiovascular Function and Risk Factors (132 papers) and Cardiac pacing and defibrillation studies (78 papers). Andrew L. Clark collaborates with scholars based in United Kingdom, United States and Germany. Andrew L. Clark's co-authors include John G.F. Cleland, Klaus K. Witte, Pierpaolo Pellicori, Andrew J.S. Coats, Kevin Goode, A Coletta, Jufen Zhang, Nikolay P. Nikitin, Stefan D. Anker and Lee Ingle and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew L. Clark

374 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wasting as independent risk factor for mortality in chronic heart failure

1997 1.1k citations Andrew L. Clark, Andrew J.S. Coats et al. profile →
Criteria for Iron Deficiency in Patients With Heart Failure

2022 114 citations Pierpaolo Pellicori, John G.F. Cleland et al. profile →

Peers

Countries citing papers authored by Andrew L. Clark

Since Specialization

Citations

This map shows the geographic impact of Andrew L. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Clark more than expected).

Fields of papers citing papers by Andrew L. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew L. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Clark. The network helps show where Andrew L. Clark may publish in the future.

Co-authorship network of co-authors of Andrew L. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew L. Clark. A scholar is included among the top collaborators of Andrew L. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew L. Clark. Andrew L. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Malnutrition, congestion and mortality in ambulatory patients with heart failure 2018 ·Heart ·Shirley Sze, Pierpaolo Pellicori, Jufen Zhang, Andrew L. Clark	57
2	Clinical Trials Update from the European Society of Cardiology–Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and Renin–Angiotensin Inhibitors in Patients with Heart and Renal Failure 2015 ·European Journal of Heart Failure ·Pierpaolo Pellicori, Andrew L. Clark	12
3	Effects of Reducing Inspired Oxygen Concentration for One Hour in Patients with Chronic Heart Failure: Implications for Air Travel 2013 ·European Journal of Heart Failure ·James Hobkirk, Thibaud Damy, (unknown), (unknown), Sarah Smith, Lee Ingle, Andrew L. Clark, John G.F. Cleland	21
4	Renal Artery Stenosis: An Innocent Bystander or an Independent Predictor of Worse Outcome in Patients with Chronic Heart Failure? A Magnetic Resonance Imaging Study 2012 ·European Journal of Heart Failure ·Christos V. Bourantas, Huan Loh, Elena Lukaschuk, (unknown), Saeed Mirsadraee, Farqad Alamgir, Ann C. Tweddel, Duncan F. Ettles, Alan S. Rigby, Nikolay P. Nikitin, Andrew L. Clark, John G.F. Cleland	11
5	Clinical Trials Update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II 2011 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, Nick Freemantle, Andrew L. Clark	4
6	Does the Physical Examination Still have a Role in Patients with Suspected Heart Failure? 2011 ·European Journal of Heart Failure ·Thibaud Damy, Anna Kallvikbacka‐Bennett, Jufen Zhang, Kevin Goode, (unknown), James Hobkirk, (unknown), Jean‐Luc Dubois‐Randé, Luc Hittinger, John G.F. Cleland, Andrew L. Clark	42
7	Clinical Trials Update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT 2011 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, (unknown), (unknown), Pierpaolo Pellicori, Nick Freemantle, Andrew L. Clark	24
8	Clinical Trials Update from the European Society of Cardiology Heart Failure Meeting 2010: TRIDENT 1, BENEFICIAL, CUPID, RFA-HF, MUSIC, DUEL, handheld BNP, Phrenic Nerve Stimulation, CHAMPION and CABG with CRT Study 2010 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, Andrew L. Clark	7
9	Clinical Trials Update from the American College of Cardiology Meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR 2010 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, (unknown), (unknown), Andrew L. Clark	41
10	European Society of Cardiology Heart Failure Association Standards for Delivering Heart Failure Care 2010 ·European Journal of Heart Failure ·Theresa A. McDonagh, Lynda Blue, Andrew L. Clark, Ulf Dahlström, Inger Ekman, Mitja Lainščak, Kenneth McDonald, Mary Ryder, Anna Strömberg, Tiny Jaarsma	170
11	Clinical Trials Update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT 2009 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, (unknown), (unknown), Azam Torabi, Andrew L. Clark	34
12	Is Taking Part in Clinical Trials Good for your Health? A Cohort Study 2009 ·European Journal of Heart Failure ·Andrew L. Clark, (unknown), Kevin Goode, John G.F. Cleland	20
13	Clinical Trials Update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, Partial Ventricular Support, FIX-HF-5, Vagal Stimulation, REVIVAL-3, Pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA 2009 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, Andrew L. Clark, Damien Cullington	25
14	Clinical Trials Update from the American College of Cardiology 2008: Carisma, Trends, Meta-Analysis of Cox-2 Studies, HAT, On-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE 2008 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, (unknown), (unknown), Damien Cullington, (unknown), Andrew L. Clark	13
15	Clinical Trials Update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the Evaluation of Dyspnoea and THIS-Diet 2007 ·European Journal of Heart Failure ·John G.F. Cleland, A Coletta, Andrew L. Clark	30
16	Effects of Applying a Standardised Management Algorithm for Moderate to Severe Renal Dysfunction in Patients with Chronic Stable Heart Failure 2006 ·European Journal of Heart Failure ·Ramesh de Silva, Nikolay P. Nikitin, Klaus K. Witte, Alan S. Rigby, Huan Loh, Anthony A. Nicholson, Sunil Bhandari, Andrew L. Clark, John G.F. Cleland	17
17	Clinical Determinants of Poor Six-Minute Walk Test Performance in Patients with Left Ventricular Systolic Dysfunction and no Major Structural Heart Disease 2005 ·European Journal of Heart Failure ·Lee Ingle, Alan S. Rigby, Samantha Nabb, (unknown), Andrew L. Clark, John G.F. Cleland	54
18	Prevalence and Predictors of Anxiety and Depression in a Sample of Chronic Heart Failure Patients with Left Ventricular Systolic Dysfunction 2005 ·European Journal of Heart Failure ·(unknown), Esme Moniz‐Cook, Andrew L. Clark, (unknown), (unknown), John G.F. Cleland	127
19	Predicting Peak Oxygen Uptake from 6-min Walk Test Performance in Male Patients with Left Ventricular Systolic Dysfunction 2005 ·European Journal of Heart Failure ·Lee Ingle, Kevin Goode, Alan S. Rigby, John G.F. Cleland, Andrew L. Clark	28
20	Exercise Training in Chronic Heart Failure: Effects on Pro-Inflammatory Markers 2004 ·European Journal of Heart Failure ·Josef Niebauer, Andrew L. Clark, (unknown), Andrew J.S. Coats	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact